fbpx Skip to main content

Vasculopathy is a common complication of sickle cell disease (SCD) that can result in end-organ damage. Leg ulcers have been reported in 5-10% of adults with SCD. A lack of information exists about the geographic distribution of patients with SCD with reported leg ulcers. An analysis was necessary to determine how geographic location affects the risk of vasculopathy in patients with SCD.

The Consortium for the Advancement of Sickle Cell Research, or CASiRe, was formed to understand the different phenotypes of patients with SCD from different ethnic groups across several geographic locations. The study consisted of 659 patients with SCD from the United States, the United Kingdom, Italy, and Ghana.

It was determined that the highest prevalence of leg ulcers was found in Ghanaians, at 18.6%, and in older, male patients with an SS genotype. Albuminuria, proteinuria, increased markers of hemolysis, lower oxygen saturation, lower body mass index, and renal dysfunction increased the risk of vasculopathy.

In conclusion, older, male patients with SCD of SS genotype, Sub-Saharan African descent, and renal impairment have the highest risk of vasculopathy. The question still remains if Sub-Saharan African ethnicity contributes to this increased risk or if other variables are at play, such as environment, lack of medical services, culture, and general health. More studies are needed to better understand the role of race/ethnicity and location in the risk of patients with SCD developing leg ulcers [1].


[1] Antwi-Boasiako, C., Andemariam, B., Colombatti, R., Asare, E. V., Strunk, C., Piccone, C. M., Manwani, D., Boruchov, D., Farooq, F., Urbonya, R., Wilson, S., Boatemaa, G. D., Perrotta, S., Sainati, L., Rivers, A., Rao, S., Zempsky, W., Ekem, I., Sey, F., . . . Campbell, A. D. (2020). A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis. Annals of Hematology, 99(9), 2073–2079. https://doi.org/10.1007/s00277-020-04057-8

You May Also Like::  Acute Kidney Injury in Patients With Sickle Cell Disease

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More